2024-01-31 |
2024-01-29 |
B
Purchase
|
MCDADE MARK
Non-Executive Director
|
100,000
+28.7%
32.50
3,250,000
USD
|
100,000
+28.7%
|
32.50
|
3,250,000
USD
|
|
2023-11-20 |
2023-11-17 |
B
Purchase
|
Kulkarni Sandeep Chidambar
CEO
Executive Director
|
4,000
+0.6%
16.99
67,960
USD
|
4,000
+0.6%
|
16.99
|
67,960
USD
|
|
2023-11-20 |
2023-11-17 |
B
Purchase
|
Thiara Parvinder
Non-Executive Director
|
1,000
+1.2%
17.31
17,310
USD
|
1,000
+1.2%
|
17.31
|
17,310
USD
|
|
2023-10-27 |
2023-10-27 |
B
Purchase
|
Castelein Caley
Non-Executive Director
|
15,800
+3.2%
14.55
229,890
USD
|
15,800
+3.2%
|
14.55
|
229,890
USD
|
|
2023-10-26 |
2023-10-26 |
B
Purchase
|
Kulkarni Sandeep Chidambar
CEO
Executive Director
|
5,000
+0.7%
12.25
61,250
USD
|
5,000
+0.7%
|
12.25
|
61,250
USD
|
|
2023-10-27 |
2023-10-25 |
B
Purchase
|
Castelein Caley
Non-Executive Director
|
4,200
+0.8%
12.07
50,694
USD
|
4,200
+0.8%
|
12.07
|
50,694
USD
|
|
2023-10-26 |
2023-10-25 |
B
Purchase
|
Thiara Parvinder
Non-Executive Director
|
2,000
+2.5%
12.12
24,240
USD
|
2,000
+2.5%
|
12.12
|
24,240
USD
|
|
2023-10-26 |
2023-10-24 |
B
Purchase
|
Kulkarni Sandeep Chidambar
CEO
Executive Director
|
4,650
+0.6%
10.68
49,662
USD
|
4,650
+0.6%
|
10.68
|
49,662
USD
|
|
2023-10-26 |
2023-10-24 |
B
Purchase
|
Thiara Parvinder
Non-Executive Director
|
5,000
+6.6%
10.66
53,300
USD
|
5,000
+6.6%
|
10.66
|
53,300
USD
|
|
2023-10-26 |
2023-10-24 |
B
Purchase
|
KANTOFF AARON
Non-Executive Director
|
7,500
+19.8%
11.86
88,950
USD
|
7,500
+19.8%
|
11.86
|
88,950
USD
|
|
2023-06-14 |
2023-06-14 |
S
Sale
|
Ildstad Suzanne
Non-Executive Director
|
12,942
-0.3%
2.49
32,244
USD
|
12,942
-0.3%
|
2.49
|
32,244
USD
|
|
2023-06-14 |
2023-06-13 |
S
Sale
|
Ildstad Suzanne
Non-Executive Director
|
14,208
-0.4%
2.56
36,338
USD
|
14,208
-0.4%
|
2.56
|
36,338
USD
|
|
2023-06-14 |
2023-06-12 |
S
Sale
|
Ildstad Suzanne
Non-Executive Director
|
16,870
-0.4%
2.59
43,725
USD
|
16,870
-0.4%
|
2.59
|
43,725
USD
|
|
2023-06-09 |
2023-06-09 |
S
Sale
|
Ildstad Suzanne
Non-Executive Director
|
25,419
-0.7%
2.46
62,637
USD
|
25,419
-0.7%
|
2.46
|
62,637
USD
|
|
2023-06-09 |
2023-06-08 |
S
Sale
|
Ildstad Suzanne
Non-Executive Director
|
40,642
-1.0%
2.48
100,772
USD
|
40,642
-1.0%
|
2.48
|
100,772
USD
|
|
2023-06-09 |
2023-06-07 |
S
Sale
|
Ildstad Suzanne
Non-Executive Director
|
75,001
-1.9%
2.39
179,095
USD
|
75,001
-1.9%
|
2.39
|
179,095
USD
|
|
2023-06-07 |
2023-06-06 |
S
Sale
|
Ildstad Suzanne
Non-Executive Director
|
25,549
-0.9%
2.53
64,596
USD
|
25,549
-0.9%
|
2.53
|
64,596
USD
|
|
2023-06-07 |
2023-06-05 |
S
Sale
|
Ildstad Suzanne
Non-Executive Director
|
7,841
-0.3%
2.52
19,755
USD
|
7,841
-0.3%
|
2.52
|
19,755
USD
|
|
2023-06-05 |
2023-06-02 |
S
Sale
|
Ildstad Suzanne
Non-Executive Director
|
15,818
-0.6%
2.50
39,616
USD
|
15,818
-0.6%
|
2.50
|
39,616
USD
|
|
2023-06-05 |
2023-06-01 |
S
Sale
|
Ildstad Suzanne
Non-Executive Director
|
15,713
-0.6%
2.56
40,177
USD
|
15,713
-0.6%
|
2.56
|
40,177
USD
|
|
2023-04-25 |
2023-04-21 |
S
Sale
|
Ildstad Suzanne
Non-Executive Director
|
15,004
-0.5%
2.35
35,231
USD
|
15,004
-0.5%
|
2.35
|
35,231
USD
|
|
2023-04-21 |
2023-04-20 |
S
Sale
|
Ildstad Suzanne
Non-Executive Director
|
46,990
-1.6%
2.33
109,313
USD
|
46,990
-1.6%
|
2.33
|
109,313
USD
|
|
2023-04-21 |
2023-04-19 |
S
Sale
|
Ildstad Suzanne
Non-Executive Director
|
21,753
-0.7%
2.16
47,056
USD
|
21,753
-0.7%
|
2.16
|
47,056
USD
|
|
2023-04-19 |
2023-04-18 |
S
Sale
|
Ildstad Suzanne
Non-Executive Director
|
49,211
-1.7%
2.15
105,804
USD
|
49,211
-1.7%
|
2.15
|
105,804
USD
|
|
2023-04-19 |
2023-04-17 |
S
Sale
|
Ildstad Suzanne
Non-Executive Director
|
99,771
-3.3%
2.14
213,530
USD
|
99,771
-3.3%
|
2.14
|
213,530
USD
|
|
2023-03-20 |
2023-03-17 |
S
Sale
|
Ildstad Suzanne
Non-Executive Director
|
10,436
-0.3%
2.06
21,543
USD
|
10,436
-0.3%
|
2.06
|
21,543
USD
|
|
2023-03-07 |
2023-03-03 |
S
Sale
|
Ildstad Suzanne
Non-Executive Director
|
6,806
-0.2%
2.06
13,992
USD
|
6,806
-0.2%
|
2.06
|
13,992
USD
|
|
2023-03-02 |
2023-03-01 |
S
Sale
|
Ildstad Suzanne
Non-Executive Director
|
29
-0.0%
2.05
59
USD
|
29
-0.0%
|
2.05
|
59
USD
|
|
2023-02-23 |
2023-02-21 |
S
Sale
|
Ildstad Suzanne
Non-Executive Director
|
3,500
-0.1%
2.05
7,185
USD
|
3,500
-0.1%
|
2.05
|
7,185
USD
|
|
2023-02-21 |
2023-02-17 |
S
Sale
|
Ildstad Suzanne
Non-Executive Director
|
3,612
-0.1%
2.05
7,406
USD
|
3,612
-0.1%
|
2.05
|
7,406
USD
|
|
2023-02-21 |
2023-02-16 |
S
Sale
|
Ildstad Suzanne
Non-Executive Director
|
2,939
-0.1%
2.06
6,040
USD
|
2,939
-0.1%
|
2.06
|
6,040
USD
|
|
2022-08-23 |
2022-08-22 |
S
Sale
|
Ildstad Suzanne
Chief Scientific Officer
Officer
|
525,000
-14.6%
2.80
1,470,000
USD
|
525,000
-14.6%
|
2.80
|
1,470,000
USD
|
|
2022-08-02 |
2022-07-29 |
B
Purchase
|
Requadt Scott
Chief Executive Officer
Executive Director
|
39,382
+8.4%
4.25
167,374
USD
|
39,382
+8.4%
|
4.25
|
167,374
USD
|
|
2022-07-28 |
2022-07-28 |
B
Purchase
|
Requadt Scott
Chief Executive Officer
Executive Director
|
3,090
+0.7%
4.25
13,133
USD
|
3,090
+0.7%
|
4.25
|
13,133
USD
|
|
2022-07-28 |
2022-07-26 |
B
Purchase
|
Requadt Scott
Chief Executive Officer
Executive Director
|
5,528
+1.2%
4.24
23,439
USD
|
5,528
+1.2%
|
4.24
|
23,439
USD
|
|
2022-07-26 |
2022-07-22 |
B
Purchase
|
Requadt Scott
Chief Executive Officer
Executive Director
|
9,444
+2.1%
3.75
35,412
USD
|
9,444
+2.1%
|
3.75
|
35,412
USD
|
|
2022-07-25 |
2022-07-21 |
B
Purchase
|
Nader Francois
Non-Executive Director
|
36,500
+35.8%
3.72
135,780
USD
|
36,500
+35.8%
|
3.72
|
135,780
USD
|
|
2022-07-25 |
2022-07-20 |
B
Purchase
|
Nader Francois
Non-Executive Director
|
52,000
+104.0%
3.62
188,240
USD
|
52,000
+104.0%
|
3.62
|
188,240
USD
|
|
2022-07-25 |
2022-07-19 |
B
Purchase
|
Nader Francois
Non-Executive Director
|
50,000
+inf%
3.52
176,000
USD
|
50,000
+inf%
|
3.52
|
176,000
USD
|
|
2021-05-14 |
2021-05-11 |
B
Purchase
|
Clarus Lifesciences III, L.P.
Major owner
|
701
+0.4%
17.00
11,917
USD
|
701
+0.4%
|
17.00
|
11,917
USD
|
|
2021-05-14 |
2021-05-11 |
B
Purchase
|
Clarus Lifesciences III, L.P.
Major owner
|
3,507
+0.4%
17.00
59,619
USD
|
3,507
+0.4%
|
17.00
|
59,619
USD
|
|
2021-05-14 |
2021-05-11 |
B
Purchase
|
Clarus Lifesciences III, L.P.
Major owner
|
1,902
+0.4%
17.00
32,334
USD
|
1,902
+0.4%
|
17.00
|
32,334
USD
|
|
2021-05-14 |
2021-05-11 |
B
Purchase
|
Clarus Lifesciences III, L.P.
Major owner
|
2,917
+0.4%
17.00
49,589
USD
|
2,917
+0.4%
|
17.00
|
49,589
USD
|
|
2021-05-14 |
2021-05-11 |
B
Purchase
|
Clarus Lifesciences III, L.P.
Major owner
|
1,444
+0.4%
17.00
24,548
USD
|
1,444
+0.4%
|
17.00
|
24,548
USD
|
|
2021-05-14 |
2021-05-11 |
B
Purchase
|
Clarus Lifesciences III, L.P.
Major owner
|
3,611
+0.4%
17.00
61,387
USD
|
3,611
+0.4%
|
17.00
|
61,387
USD
|
|
2021-05-14 |
2021-05-11 |
B
Purchase
|
Clarus Lifesciences III, L.P.
Major owner
|
15,918
+0.3%
17.00
270,606
USD
|
15,918
+0.3%
|
17.00
|
270,606
USD
|
|
2021-05-13 |
2021-05-11 |
B
Purchase
|
Clarus Defined Exit I, L.P.
Major owner
|
701
+0.4%
17.00
11,917
USD
|
701
+0.4%
|
17.00
|
11,917
USD
|
|
2021-05-13 |
2021-05-11 |
B
Purchase
|
Clarus Defined Exit I, L.P.
Major owner
|
3,507
+0.4%
17.00
59,619
USD
|
3,507
+0.4%
|
17.00
|
59,619
USD
|
|
2021-05-13 |
2021-05-11 |
B
Purchase
|
Clarus Defined Exit I, L.P.
Major owner
|
1,902
+0.4%
17.00
32,334
USD
|
1,902
+0.4%
|
17.00
|
32,334
USD
|
|
2021-05-13 |
2021-05-11 |
B
Purchase
|
Clarus Defined Exit I, L.P.
Major owner
|
2,917
+0.4%
17.00
49,589
USD
|
2,917
+0.4%
|
17.00
|
49,589
USD
|
|
2021-05-13 |
2021-05-11 |
B
Purchase
|
Clarus Defined Exit I, L.P.
Major owner
|
1,444
+0.4%
17.00
24,548
USD
|
1,444
+0.4%
|
17.00
|
24,548
USD
|
|
2021-05-13 |
2021-05-11 |
B
Purchase
|
Clarus Defined Exit I, L.P.
Major owner
|
3,611
+0.4%
17.00
61,387
USD
|
3,611
+0.4%
|
17.00
|
61,387
USD
|
|
2021-05-13 |
2021-05-11 |
B
Purchase
|
Clarus Defined Exit I, L.P.
Major owner
|
15,918
+0.3%
17.00
270,606
USD
|
15,918
+0.3%
|
17.00
|
270,606
USD
|
|
2021-05-11 |
2021-05-11 |
B
Purchase
|
Longitude Capital Partners III, LLC
Major owner
|
235,000
+7.9%
17.00
3,995,000
USD
|
235,000
+7.9%
|
17.00
|
3,995,000
USD
|
|